Ventricular Cardiac Organoid

  • Ventricular Cardiac Organoid

Human iPSC-derived Ventricular Cardiac Organoid

These organoids are generated from human iPSCs to model the structural and functional characteristics of ventricular myocardium in a 3D format. They exhibit synchronized contractions, robust ventricular-like electrophysiology, and chamber-specific gene expression, making them powerful systems for disease modeling, drug testing, and safety pharmacology.

Benefits

  • 3D organoid structure mimicking ventricular tissue architecture
  • Chamber-specific electrophysiological and contractile properties
  • Useful for cardiac safety pharmacology and disease modeling

Product Specifications

Feature

Detail

Identity Markers

High expression of ventricular markers (MLC2v, TNNT2, α-actinin); downregulation of pluripotency markers

Quantities

≥ 1 × 10⁶ cells per organoid; batch sizes available

Quality Control

Electrophysiological assays (Voltage/Calcium probes), contractility assays, mycoplasma testing

Format

Cryopreserved 3D organoids

Donor & Reprogramming

Healthy or disease-specific donor; Sendai virus reprogramming

Shipping / Storage

Dry shipper at -180°C to -135°C; store in vapor phase LN₂

Supplied with

Organoid culture medium and user-guide

Explore Ventricular Cardiac Organoid

Unlock advanced cardiac research with our iPSC-derived ventricular cardiac organoids, designed to mimic native 3D heart tissue structure and function. Review the product details to see how these organoids can accelerate your studies in disease modeling, drug testing, and cardiac safety assessment.

Our Products